Alaina Geiss, PA
Medical · Rock Hill, SCNPI 1588377378
Payments from drug & device makers
Across 97 payments — averaging $25.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$673
- UCB, Inc.$347
- Regeneron Healthcare Solutions, Inc.$278
- Galderma Laboratories, L.p.$240
- Pfizer$211
- Sanofi$204
- plus $566 from 8 others
What the payments were for
- Food & beverage$2,30391%
- Education$2179%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 17 | $673 |
| UCB, Inc. | 15 | $347 |
| Regeneron Healthcare Solutions, Inc. | 9 | $278 |
| Galderma Laboratories, L.p. | 10 | $240 |
| Pfizer | 7 | $211 |
| Sanofi | 9 | $204 |
| Sun Pharmaceutical Industries Inc. | 7 | $152 |
| AbbVie | 11 | $142 |
| Lilly USA, LLC | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 1 | $67 |
| Novartis | 3 | $54 |
| Incyte Corporation | 2 | $37 |
| Organon | 2 | $30 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$417
- SIMPONI ARIA$145
- NEMLUVIO$125
- LITFULO$121
- Bimzelx$101
How this compares
$2,519 in reported general payments places this provider in the 70th percentile of 384 medical providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 40 | $514 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $339 |
| Ondansetron OdtOndansetron | 31 | $277 |
| Clindamycin Hcl | 11 | $188 |
| Cefdinir | 13 | $163 |
| Cyclobenzaprine Hcl | 24 | $108 |
| Dicyclomine Hcl | 19 | $104 |
| Prednisone | 34 | $86 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $84 |
| Tizanidine Hcl | 20 | $78 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $62 |
Paid to pharmacies, not to this prescriber.
Other medical in Rock Hill
- Darin GrayRock Hill$16K
- Christopher ThompsonSpartanburg$78K
- Laura BuchGreenville$73K
- Suzanne SmithWest Columbia$39K
- Stavros ChrysostomidesColumbia$39K
- Ethan CaseySpartanburg$24K
- Jessica HallColumbia$22K
- Mary MacdonaldCharleston$20K
- Cameron PappasGreenville$18K
- Leslie RumbautGrenville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.